Temporomandibular Joint Osteoarthritis Mechanisms and Treatments

Temporomandibular joint osteoarthritis (TMJ OA) is a degenerative disorder characterised by progressive cartilage breakdown, subchondral bone remodelling and joint dysfunction. Central to its pathogenesis are chondrocyte apoptosis, dysregulated extracellular matrix turnover and mechanical overload. Inflammatory mediators such as interleukin-1β and tumour necrosis factor-α activate signalling cascades including NF-κB and Wnt/β-catenin, driving catabolic enzyme production and further matrix degradation. Age-related senescence and obesity-related metabolic changes exacerbate cartilage damage via oxidative stress and altered adipose-derived extracellular vesicle profiles. Concurrent loss of subchondral bone homeostasis contributes to osteophyte formation and pain. On the treatment front, management spans conservative interventions—physiotherapy, occlusal splints and non-steroidal anti-inflammatories—to minimally invasive surgeries such as arthrocentesis. Emerging regenerative strategies focus on cartilage repair and anti-inflammatory modulation through platelet-rich plasma, mesenchymal stem cell-derived exosomes, biomaterial scaffolds and pharmacological agents targeting key pathways. Nanocarrier systems enabling sustained release of growth factors or inhibitors promise targeted attenuation of catabolic signalling. Preclinical and early clinical data highlight the potential of combinatorial approaches to restore joint homeostasis, alleviate pain and improve jaw function, underscoring the global imperative to translate mechanistic insights into effective, long-term therapies.

Research from Nature Portfolio

Investigators have demonstrated that intra-articular injection of vascular endothelial growth factor into the temporomandibular joint of mice directly induces osteoarthritic lesions. Treated joints exhibit accelerated cartilage erosion, elevated expression of matrix metalloproteinases and receptor activator of NF-κB ligand, increased chondrocyte apoptosis and pronounced subchondral bone resorption. In vitro and imaging studies confirm that exogenous VEGF promotes osteoclast differentiation and synovial inflammation, revealing a causal role for angiogenic signalling in TMJ OA initiation and progression.

Temporomandibular Joint Osteoarthritis Mechanisms and Treatments publication trend

The graph below shows the total number of articles in temporomandibular joint osteoarthritis mechanisms and treatments across all publications each year (not limited to Nature Index journals).

Technical terms

Temporomandibular joint (TMJ): Articulation between the mandible and temporal bone enabling jaw movement.

Osteoarthritis (OA): Degenerative joint disease marked by cartilage loss and bone remodelling.

Chondrocyte: Specialized cell responsible for cartilage matrix synthesis and maintenance.

Subchondral bone: Layer of bone immediately beneath cartilage, involved in load distribution.

Extracellular matrix (ECM): Structural network of proteins and glycosaminoglycans surrounding joint cells.

Matrix metalloproteinases (MMPs): Enzymes that degrade ECM components, driving cartilage breakdown.

Wnt/β-catenin signalling: Pathway regulating cell differentiation and matrix turnover, often overactivated in OA.

Mesoporous silica nanoparticles: Porous nanocarriers used for sustained drug or growth factor delivery.

Extracellular vesicles (EVs): Membrane-bound particles released by cells that transfer bioactive molecules.

References

1. Microgel Encapsulated Mesoporous Silica Nanoparticles for Releasing Wnt16 to Synergistically Treat Temporomandibular Joint Osteoarthritis. Advanced Science (2024).
2. Platelet-derived biomaterial with hyaluronic acid alleviates temporal-mandibular joint osteoarthritis: clinical trial from dish to human. Journal of Biomedical Science (2023).
3. Adipose tissue‐derived extracellular vesicles aggravate temporomandibular joint osteoarthritis associated with obesity. Clinical and Translational Medicine (2024).
4. Injecting vascular endothelial growth factor into the temporomandibular joint induces osteoarthritis in mice. Scientific Reports (2015).